Wednesday 4th May, 2022

18:00 - 20:00	The Anglonordic Drinks Reception An exclusive Reception hosted by H.E. the Ambassador of Denmark to the UK. Further details will be sent to delegates who are registered to attend the Anglonordic conference. The reception is organised in collaboration with Invest in Denmark, part of the Ministry of Foreign Affairs of Denmark. Capacity has been reached, a waiting list now applies.

18:00 - 20:00

The Anglonordic Drinks Reception

An exclusive Reception hosted by H.E. the Ambassador of Denmark to the UK. Further details will be sent to delegates who are registered to attend the Anglonordic conference. The reception is organised in collaboration with Invest in Denmark, part of the Ministry of Foreign Affairs of Denmark. Capacity has been reached, a waiting list now applies.

Thursday 5th May, 2022

1:1 meetings take place throughout the day and are pre-booked online.

08:15 - 09:00	Registration
09:00 - 09:05	Welcome Mary Clark, MD Session Chair Optimum Strategic Communications Mattias Johansson, The Anglonordic Conference Founder Director of Ezenze
09:05 - 09:30	Keynote Gil Bar-Nahum Keynote Speaker Jefferies
09:30 - 10:15	Panel Discussion: Trends in Life Science Investments Europe’s leading investors will provide an overview of their outlook on the market, as well as current and future trends that are driving investment in the healthcare sector. Expect an insightful discussion around why some areas are so popular, challenges & opportunities around investing in these spaces plus horizon scanning for the year ahead. Stephen Hansen, Session Chair BioCentury Hakan Goker, M Ventures Henrijette Richter, Sofinnova Partners Marten Steen, HealthCap Roel Bulthuis, INKEF Capital Søren Møller, Novo Holdings
10:15 - 10:30	Coffee Break, Exhibition, Networking
10:30 - 11:00	Workshop: Venture Capital and Collaborations in the Life Sciences Sector – Overview of Investment Rounds and Licensing Arrangements This interactive workshop, hosted by McDermott Will & Emery, will provide an overview of key considerations for venture capital investment rounds for early stage life sciences companies as well as licenses and collaborations. The workshop will comprise two parts: Part A: Investment Round Fundamentals – Including: documentation involved; due diligence process; key deal concepts (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution); restrictions on founders; and, jurisdictional differences Part B: Licensing Arrangements – Including: the “anatomy” of a licensing/collaboration term sheet, and how that might translate into the definitive agreement Arvin Abraham, Workshop Instructor McDermott Will & Emery Gary Howes, Workshop Instructor McDermott Will & Emery
11:00 - 12:30	Company Presentations Presentations take place in the: Biotechnology Room - drug discovery and delivery companies in all therapeutic areas. Presenting Companies: Vivesto, Cbio A/S, Trobix Innovation, Sartar Therapeutics, Paras Biopharmaceuticals Finland Oy, Lytix Juan R. Garcia, Session Chair Biotechnology Business Institute Technology Room - medical devices, diagnostics, platform technologies and healthcare related product development Presenting Companies: Oxford Endovascular, Wellthy Therapeutics, Curapel, Flash Diagnostics, NanoSyrinx, Parkinsongs Gwyn Tudor, Session Chair MediWales and Lifescience Industry News
12:30 - 13:00	Lunch, Exhibition, Networking
13:00 - 13:45	Panel Discussion: RNA in the Spotlight A panel of industry experts and investors will discuss this exciting field of medicine which after a decade of painstaking progress, is finally poised to become a widely-applicable approach. RNA therapy now has the potential to treat a wide variety of diseases, including cardiovascular disease, and cancer. Expect honest insights, discussions on the rapid advances that have been made and the technologies being developed. Donna Hackett, Session Chair The Francis Crick Institute Ralph Lindemann, Merck Steven Powell, eTheRNA Oliver Rausch, STORM Therapeutics
13:45 - 15:30	Company Presentations Presentations take place in the: Biotechnology Room - drug discovery and delivery companies in all therapeutic areas Presenting Companies: Bit Bio, Leucid Bio, MediSieve, Pharma Holdings, Phaim Pharma, Scandion, Leadartis Kam Dhaliwall, Session Chair Bit bio Technology Room - incl.Guest Country Delegations: drug discovery and delivery companies in all therapeutic areas Presenting Companies: Edity Therapeutics, InProTher, Regemat 3D, Mirnax, Biohope, A4CELL Nanodevices, Immunorizon Juan R. Garcia, Session Chair Biotechnology Business Institute
15:30 - 16:00	Coffee Break, Exhibition, Networking
16:00 - 16:45	Panel Discussion: Anticipated Developments in Neuroinflammation Therapies Because neuroinflammation has been associated with a variety of neurodegenerative diseases, there is increasing interest to determine whether reducing inflammation will reverse neurodegeneration, chronic pain and many other conditions. Leading industry experts will discuss the anticipated developments. Richard Staines, Session Chair BioWorld Maria Ferretti, Women's Brain Health Hugh Nuthall, Eli Lilly Alan Watt, NodThera Rob Pinnock, Biogen
16:45 - 17:45	Panel Discussion: If I knew then what I know now Mike Ward chairs a panel of industry executives who will reflect on previous experiences and discuss key learnings from their careers. Mike Ward, Session Chair Clarivate Michel de Baar, MSD Georg Büchner, Helsinn Group Catherine Moukheibir, Non Executive Board Member Carolyn Porter, Cytoseek Deborah Spencer, University of Oxford
17:45 - 17:50	Conclusions Reflections on the days themes and topics by: Hakan Goker, M Ventures Mary Clark, MD Optimum Strategic Communications
17:50 - 18:30	Drinks Reception - sponsored by Barrington James Mattias Johansson (Host), The Anglonordic Life Science Conference Founder Director of Ezenze